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Introduction 
There has been increasing interest recently in the presentation and packaging of drugs for elderly 
patients and the manufacture of child-proof containers. This had led to the development of specially 
designed bottles or blister packs now commonly used fur over the counter analgesic preparations. 
Rheumatoid arthritis and osteoarthrosis are common diseases and many patients suffering from these 
diseases develop considerable deformities of the hand leading to an inability to perform activities of 
daily living. In a previous study (Mason, et al, (1) 200 patients with rheumatoid arthritis were shown to 
have difficulty in opening child-proof containers. In this study we decided to include patients with 
osteoarthrosis as well and to test the ability of both rheumatoid and osteoarthritic patients to open 
blister packs as well as child-proof containers. 
 
Materials and Methods 
96 patients attending the Outpatient Clinic at Flinders Medical Centre or Daw Park Repatriation 
Hospital took part in the study. All patients had definite or classical rheumatoid arthritis according to 
the diagnostic criteria of the American rheumatism Association (Ropes et al, (959),(2) or had primary 
osteoarthrosis with Heberden’s and Bouchard’s nodes. There were 61 patients with rheumatoid arthritis 
and 35 patients with osteoarthrosis. The mean age of the patients was 61 years and there were 54 
females and 42 males. 
Five containers all empty and unlabelled (except fist the foil) were studied. The five 
containers investigated arc as seen in Figure 1 and include SRA (Boots), Ferrogradumets (Abbotts). 
Child-proof dispensing bottle 90 mls (ACI), RGH Daw Park dispensing bottle 90 mls (ACI) and 
Capadex in foil (Fawns and McAllan). Containers were presented to the patient in a random order and 
the time taken to open each of the containers was measured accurately on a stop-watch. Ferrogradumet 
containers also included instructions on the bottle and the patient was asked to read these aloud. 
Patients who deviated from what was actually written in any way were deemed unable to read the 
instructions accurately. Patients unable to open a particular container or taking longer than one minute 
were given instruction in how he or she might open the container. Approximately fifteen minutes later 
the patient was re-tested and timed again. A functional index was performed using a modification of 
the method of Lee et al. (3) 
 
Results 
The mean time for rheumatoid and osteoarthritic patients to open each container is seen in the Table. It 
can be seen that all but one of the patients were able to open the screw-cap container. 90% were able to 
remove the Capadex capsules from the blister pack and approximately two-thirds of the patients were 
able to open each of the child-proof containers without instruction. 90% of patients regularly took one 
or more medications from the containers. 25% of patients were not able to read the instructions 
displayed on the three child-proof containers, a small proportion because they were not wearing their 
reading glasses.  
Approximately 40% of patients did not read the instructions for opening the 
child-proof containers and this appeared to be a major reason for inability to open containers, 
particularly in these patients who were not severely disabled. Of those people who did read the 
instructions, 84% were able to open the container concerned whereas 411% of the people who did not 
read instructions were able to open the container.  
A functional index questionnaire was performed to establish and measure arthritis disability 
according to a modification of the method of Lee et al.(3) Only those questions which directly related 
to hand and finger function were asked. Patients could score between 0 (not disabled) and 40 (severely 
disabled). The Table shows the relationship between the percentage of patients opening each bottle in 
The Australian Journal of Pharmacy, October 1981 
 
less than one minute and the functional index. Patients who were unable to open a container or took 
longer than one minute to open a container were instructed on how they might open the container. In 
all, 480 tests were performed and 108 instructions were necessary. 60% of these instructions were 
successful in that the patient was able to open the container relatively easily, usually within 20 seconds. 
86% of patients with a functional index of less than 10 could be taught to open a container, whereas 
only 534 of the patients with a functional index of greater than 10 could be taught to open the 
containers. Overall very few patients entered into the study were ultimately unable to open child-proof 
containers after instruction. 
Whilst child-proof containers to reduce the incidence of poisoning in children are important 
(4), special consideration must he given to severely handicapped people requiring medication. 
Although more than two-thirds of patients could open the containers some major areas of difficulty 
appear. 
 
Percentage of patients opening each container, mean time taken and relation-
ship to functional index 
 
Container % of patients able to open
bottle in < 1 minute 
Mean time taken (secs) 
± standard error 
SRA (sustained release aspirin) 68 32 ± 3.76 
Ferrogradumet 70 21 ± 2.00 
Flip-Top 65 24 ± 2.84 
Screw-Cap 98 5 ± 0.34 
Blister Pack 92 12 ± 1.38 
 
 
Functional Index (Lee et al) % of patients able to open all containers 
<6 88
6<13 83
7<13 53 
 
These were the extent of the patient’s arthritic disease, the patient’s ability to read the 
instructions and the patient’s not reading the instructions. Perhaps more consideration should be given 
to these people when child-proof containers are designed. In particular it appears necessary to use large 
print for the instructions on the containers. Obviously the less complex the instructions and manoeuvres 
required, the easier for the handicapped patients. The SRA container and the flip-top containers often 
posed problems to the patients because they could not understand what was required of them. Overall 
very few patients entered into the study were ultimately unable to open the child-proof containers after 
instruction. It would appear that the main reason for an unsuccessful outcome of instruction was 
physical inability rather than inability to comprehend the necessary manoeuvres. We wish to alert the 
Medical and Pharmaceutical profession to the difficulties some patients may experience with these 
containers. We would suggest the Medical profession make sure they are aware of the arthritic patient’s 
abilities to open these containers, making special note on any prescription ordered if they feel the patient 
has difficulty. Pharmacists should be willing to counsel patients on the use of these containers and 
supply screw-capped containers when necessary. 
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